Biomarkers: Key to Precision Therapy for Cancer

In recent years, biomarkers have significantly transformed the field of oncology, offering crucial resources for rapid diagnosis, patient grouping, and personalized care. These biological indicators in body fluids and tissues facilitate differentiation between healthy and diseased states, predict clinical outcomes, and track therapeutic responses. This article delves into their utility for advancing precision medicine, from discovering important molecules such as carcinoembryonic antigen (CEA) to revolutionary advances in genomics, proteomics, and nanotechnology. It also investigates their use in various cancer types, including lung, breast, and prostate cancers, shedding light on emerging biomarkers and obstacles such as tumor diversity and sensitivity limitations. Despite these obstacles, biomarkers have the potential to reshape cancer treatment, elucidating the path to more efficient and less invasive solutions and revolutionizing both research and clinical efforts.